American Century Companies Inc Point Biopharma Global Inc. Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.67 - $9.71 $2.77 Million - $4.04 Million	416,006 Added 109.88%	794,611 $5.3 Million
Q2 2023 Aug 14, 2023	BUY	$6.86 - $10.86 $2.44 Million - $3.87 Million	356,261 Added 1594.44%	378,605 $3.43 Million
Q1 2023 May 11, 2023	BUY	$6.78 - $8.1 $64,043 - $76,512	9,446 Added 73.24%	22,344 $162,000
Q4 2022 Feb 13, 2023	BUY	$5.72 - $9.78 $7,132 - $12,195	1,247 Added 10.7%	12,898 $94,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $84,353 - $120,121	11,651 New	11,651 $90,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.